Collegium Pharmaceutical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell COLL and other ETFs, options, and stocks.

About COLL

Collegium Pharmaceutical, Inc. is a dynamic, biopharmaceutical company delivering medicines with formulation and delivery innovation for people living with complex central nervous system and pain conditions. The firm has spent more than a decade proving that responsible stewardship and bold, science-backed approaches can redefine what treatment looks like in categories too often shaped by complexity and misconceptions. 

CEO
Vikram Karnani
CEOVikram Karnani
Employees
423
Employees423
Headquarters
Stoughton, Massachusetts
HeadquartersStoughton, Massachusetts
Founded
2002
Founded2002
Employees
423
Employees423

COLL Key Statistics

Market cap
813.40M
Market cap813.40M
Price-Earnings ratio
25.77
Price-Earnings ratio25.77
Dividend yield
—
Dividend yield—
Average volume
687.01K
Average volume687.01K
High today
$26.23
High today$26.23
Low today
$25.01
Low today$25.01
Open price
$25.36
Open price$25.36
Volume
155.54K
Volume155.54K
52 Week high
$50.79
52 Week high$50.79
52 Week low
$21.43
52 Week low$21.43

Stock Snapshot

As of today, Collegium Pharmaceutical(COLL) shares are valued at $26.18. The company's market cap stands at 813.4M, with a P/E ratio of 25.77.

As of 2026-11-18, Collegium Pharmaceutical(COLL) stock has fluctuated between $25.01 and $26.23. The current price stands at $26.18, placing the stock +4.7% above today's low and -0.2% off the high.

The Collegium Pharmaceutical(COLL)'s current trading volume is 155.54K, compared to an average daily volume of 687.01K.

In the last year, Collegium Pharmaceutical(COLL) shares hit a 52-week high of $50.79 and a 52-week low of $21.43.

In the last year, Collegium Pharmaceutical(COLL) shares hit a 52-week high of $50.79 and a 52-week low of $21.43.

COLL News

Investing.com 1d
Collegium Pharmaceutical at Jefferies Global Healthcare Conference: growth bets - Investing.com

...

Collegium Pharmaceutical at Jefferies Global Healthcare Conference: growth bets - Investing.com

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

People also own

Based on the portfolios of people who own COLL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.